Shares in Glaukos (NYSE:GKOS) have fallen today after the diabetes-focused medical device maker missed expectation on Wall Street with its 2nd quarter earnings results.
The San Clemente, Calif.-based company posted losses of $3.3 million, or 10¢ per share, on sales of $41.3 million for the 3 months ended June 30, seeing profits swing 241.6% into losses while sales grew 44.6% compared with the same period last year.
Read the whole story on our sister site, Drug Delivery Business
The post Glaukos shares fall on Q2 sales, EPS miss appeared first on MassDevice.
from MassDevice http://ift.tt/2uo5vMg
Cap comentari:
Publica un comentari a l'entrada